Novozymes A/S is a Denmark-based biotechnology company, engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company�s business consists of two segments. The Enzyme Business segment is engaged in the development, production, and distribution of enzymes. The segment is divided into four areas, namely Household care enzymes, Food and beverage enzymes, Bioenergy enzymes, and Feed and other technical enzymes. The BioBusiness segment uses fermentation technology to produce proteins other than enzymes. It is divided into two areas, namely Microorganisms, including a diverse group of microscopic organisms with such application areas, as the industrial and municipal wastewater treatment, as well as to clean surfaces, such as carpets and drain lines, and Biopharma, comprising proteins and other biological substances used in the pharmaceutical industry. In February 2013, the Company acquired the enzymes business of Iogen Corporation.